|
HS Code |
310835 |
As an accredited 5-(4-Bromo-Phenyl)-2H-Tetrazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-(4-Bromo-Phenyl)-2H-Tetrazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Nobody likes unpredictable results in the lab, especially when it comes to intermediates like 5-(4-Bromo-Phenyl)-2H-Tetrazole. It’s a compound that catches the interest of researchers across both chemical and pharmaceutical fields because it does more than just fill a gap as a building block. Sitting at the intersection of organic chemistry and applied research, this compound brings flexibility and reliability to study design, method development, and process optimization.
Right out of the bottle, 5-(4-Bromo-Phenyl)-2H-Tetrazole, often referred to by its CAS number or abbreviated name in the lab, looks like a typical white or off-white powder—nothing flashy. What matters, though, shows up in its molecular structure. You get the familiar aromatic ring, swapped from its usual electron soup for a heavy bromine atom, and paired with the high-nitrogen-packed tetrazole. This small shift in structure brings some large differences in chemical reactivity and suitability, both in scale-up synthesis and academic work.
A lot of people have asked me, “Why not just use a standard phenyl tetrazole, or even another substituted one?” Those questions usually come just before someone tries a new reaction and finds the old standards can’t deliver yield or selectivity under mild conditions. Swapping in a para-bromo group opens the door for new coupling strategies, especially in Suzuki-Miyaura and Buchwald-Hartwig couplings. The electron-withdrawing bromine atom not only influences those cross-coupling pathways but often helps avoid harsh, condition-intensive steps.
Back during my time working at a midsize contract lab, workload often came down to client demand for new heterocycle scaffolds. In that setting, 5-(4-Bromo-Phenyl)-2H-Tetrazole became a stable companion. Most substituted tetrazoles show some instability in solution; you see it in reaction consistency and yields. This brominated version stands up to basic handling and common solvents, so day-to-day headaches about decomposition and reaction drift shrink a lot.
You’ll notice that this compound has a little bit of a reputation for being the “go-to” intermediate for certain antiviral and CNS research programs. The tetrazole ring has a knack for mimicking carboxylic acids, and the added bromine can open pathways for quick functional group exchanges. I saw this firsthand during lead optimization efforts in several projects: when the standard phenyl tetrazole didn’t cut it on solubility or metabolic stability, the brominated analog gave us a fresh shot at making things work.
Chemists and product developers often focus on purity and melting point. For 5-(4-Bromo-Phenyl)-2H-Tetrazole, most suppliers offer purity upwards of 98 percent as checked by HPLC or GC, and a melting point that helps spot batches that might have picked up trace solvents or byproducts. During a few scale-up runs in a past project, the melting point not only served as a reference for batch quality but also helped highlight any deviations before they could creep into downstream steps.
Handling characteristics matter. This powder is usually free-flowing and stable under common storage conditions, which means no scrambling for desiccators or warning labels every time you open the bottle. I’ve found this reassuring; storage blunders have a way of biting you months down the line when shelf stability is poor. I’ve even been able to use lots that sat around for eight months with zero drop in reaction yield or purity, something that isn’t always true for more exotic heterocycles.
Ask anyone who works with tetrazoles and they’ll mention substitution pattern first. Unsubstituted phenyl tetrazoles and ones with different halogens—like chloro or fluoro groups—often show different reactivities. The 4-bromo compound stands in a bit of a sweet spot: the bromine atom carries enough bulk for meaningful substitution without cranking up steric hindrance the way an ortho bromo or iodine might. Its reactivity matches up with both electron-rich and electron-deficient partners, and that versatility sets it apart from either the unsubstituted or the 2- or 3- bromo analogs, which sometimes behave unpredictably under cross-coupling or nucleophilic aromatic substitution.
Sitting across from fresh graduates during onboarding, I’d see them reach for the cheapest substituted tetrazole and then run straight into purification headaches. The 5-(4-bromo-phenyl) version often gives cleaner products and easier workups because of its solid-lattice crystal form. I spent weeks of my own Ph.D. time dragging through sticky oils and half-crystallized masses; getting a clean, filterable solid on the first precipitation is a gift every lab worker appreciates, even if it doesn’t make the annual report.
Compared to compounds with electron-donating groups on the phenyl ring, the brominated analog generally slows down side reactions, keeping unwanted overreaction to a minimum. I once watched a colleague try to swap out a methoxy for a bromo group and watch the yield nearly double, all because the more stable intermediate held up to the temperature ramp needed for the cyclization step.
Plenty of chemists only look at tetrazoles as puzzle pieces for academic synthesis, but their reach goes well beyond test tubes and reaction vials. Pharmaceutical developers chase after these intermediates when they need metabolic stability without sacrificing binding efficiency. The tetrazole ring is the bioisostere of choice for many enzyme inhibitors, especially angiotensin receptor blockers and newer CNS drugs. The presence of bromine here doesn’t just contribute mass; it lends itself to radio-labeling and imaging, where a simple exchange leaves an iodine- or fluorine-labeled variant in minutes—ideal for probing metabolic pathways by PET or SPECT scans.
Early-career as well as seasoned medicinal chemists gravitate to this specific analog because its solid-state properties and coupling ease fit comfortably into high-throughput library synthesis. Several CROs send out precisely this kind of intermediate when clients demand milligram to kilogram batches in tight timelines. Time and again, large screening libraries with functionalized tetrazoles, especially the 4-bromo variant, accelerate early-stage SAR (structure-activity relationship) programs because they blend ease of handling with cross-coupling compatibility.
Beyond the pharma world, materials science and agricultural research make good use of tetrazoles like this. In organic electronics, attaching a tetrazole can tweak electronic properties and affect stacking. The bromo group, in particular, sometimes behaves as a convenient stepping stone for B–N, B–C, or aryl-aryl bond formation in the synthesis of OLED materials or molecular sensors. On more than one occasion, colleagues in a materials lab explained how the reliability of coupling reactions with this scaffold made exploratory synthesis less risky—a big win for anybody aiming for publishable results with minimal startup effort.
Everyday handling counts. I learned my lesson after watching a hundred-gram order of another substituted tetrazole cake up after a week of humidity exposure, which spelled double the prep work in the following months. The 5-(4-Bromo-Phenyl)-2H-Tetrazole doesn’t put up the same fight. Standard ventilation and personal protective equipment suffice. Solubility follows a predictable trend in common organic solvents, and it resists the sticky messes other nitrogens-rich intermediates love to present. It’s never going to be as forgiving as simple aromatics, but routine care and dry storage keep this compound in working order long past its shelf label.
Documented toxicity data focuses on standard chemical safety for aryl halides and tetrazoles. Small-scale synthesis in a teaching lab and kilo-scale work in industrial set-ups both rely on the same safety sense: gloves, glasses, and no cutting corners. Most health and safety reports mention low acute toxicity by inhalation or skin contact, based on the handling characteristics and structure. Always worth reviewing recent literature; new findings in safety pop up from time to time for little-studied compounds.
Optimizing workflow with 5-(4-Bromo-Phenyl)-2H-Tetrazole comes down to straightforward, good habits. For synthetic scale-up, patience during solvent selection pays off. I learned to avoid stubborn solvents that leave residues, especially in multistep syntheses. Slight tweaks in bases and catalysts during palladium-mediated reactions make yields climb, particularly when working above gram scale.
Anyone chasing green chemistry finds some mileage in careful process design here. Cross-coupling reactions with this substrate often run smoother at lower catalyst loadings, keeping both metal content and cost in check. For teams under regulatory pressure to cut down on toxic waste, the drop in side reactions compared to more delicate tetrazole derivatives eases both compliance and downstream cleanup.
Data reproducibility remains a constant challenge, especially with N-heterocycles. I recall the frustration of scaling up a synthesis published with good numbers, only to grind through trial-and-error tweaks at each 10x increase in batch size. The more robust melting range and manageable hygroscopicity of 5-(4-Bromo-Phenyl)-2H-Tetrazole have saved me hours over less stable counterparts during kilo-scale preparations.
Scaling up bespoke compounds rarely runs smoothly. Problems like batch variability, crystallization unpredictability, or poor purification rear up quickly in real production. My experience shows that running small pilot reactions, freezing in proper solvent and precipitation conditions, and vetting raw material sources make a big difference. Collaborative partnerships between synthesis groups and analytical teams helped me catch out-of-spec lots before a full production run, preventing waste and lost days on the back end.
In academic and startup environments, procurement can pose a challenge for less common intermediates. Interested researchers might push for expanded catalogue listings with both small packs and bulk options, as well as inclusion in shared chemical libraries. Building stronger relationships with trusted suppliers who can deliver both technical and logistical support pays dividends for small labs and major process teams alike.
Sustainability efforts continue to push against classic halogen chemistry. 5-(4-Bromo-Phenyl)-2H-Tetrazole occupies a middle ground—it behaves sufficiently robust for clean reactions, but its production still depends on halogen-based feedstocks. Industry-wide, pressure grows for alternatives or greener ways to recycle halide byproducts. Teams I’ve worked with often pressure-test reactions with other leaving groups, yet return to the bromo analog for that rare mixture of price, purity, and cross-coupling ease. Open channels between suppliers and users could further develop cleaner halogenation and isolation strategies, steering the field toward more environmentally responsible options without trading away effectiveness.
Few things ruin a project timeline like finding out your intermediate is off-spec. During a collaboration with a pharmaceutical chemistry team, an off-batch of a related tetrazole with even a minor impurity pushed back final API delivery by weeks. With reliable 5-(4-Bromo-Phenyl)-2H-Tetrazole, those issues shrink because tighter controls on manufacturing and batch testing keep surprises at bay. Lot-to-lot consistency pays back every time, whether for single reactions or multi-kilo manufacturing.
This compound offers a real-time example of the difference between good and excellent chemical supply chain management. My time in both research and quality management roles taught me to favor suppliers who document analytical data up front, handle shipping professionally, and share insights on storage. In a crunch, these details translate into time not wasted troubleshooting avoidable problems or fielding uncomfortable post-mortem reports with upper management.
The best advances in chemical production come from open feedback between users and manufacturers. Every cycle of feedback—be it from process engineers fine-tuning reaction scales, or academic groups seeking new functional analogs—broadens the product’s suitability for practical tasks. Consistent dialogue, particularly about product improvements and shipping logistics, boosts everyone’s outcomes. I found that occasionally looping back to detailed user reports spurred suppliers to address points like packaging, documentation, and expedited delivery, benefiting both sides in future transactions.
Chemists keen to refine both product quality and application scope can push for further analytical characterization, such as expanded NMR or LC-MS traces. This helps head off any surprises once the compound enters multi-step syntheses. Industry consortia could include this compound in routine benchmarking studies to compare across batches, production facilities, and application types, building a deeper knowledge base drawn from real-world use rather than marketing brochures.
Synthetic research never sits still, and neither do expectations for high-performing intermediates. Adoption of 5-(4-Bromo-Phenyl)-2H-Tetrazole across sectors keeps pressure on suppliers to maintain high standards. Users have every reason to keep providing feedback on performance, stability, and issue resolution while raising the bar on environmental performance. Future directions might revolve around greener syntheses, more precise batch controls, and tighter regulatory alignment, reflecting changing industry and societal demands.
Every experience working with this compound, whether on the benchtop or in scaled reactors, reinforces that small structural differences can mean the world to chemical process efficiency and research breakthroughs. Good practice, clear communication, and a shared commitment to pushing the next boundary keep this product and its users at the center of progress in both science and industry.